Saiju Jacob

Research output

Research output per year 2005 2005 2008 2019 2020 2023

• 53 Article
• 4 Review article
• 1 Editorial
• 1 Letter

Research output per year

Research output per year

Search results

• 2005

  Gluten sensitivity and neuromyelitis optica: two case reports

  Jacob, S., Zarei, M., Kenton, AR. & Allroggen, H., Jul 2005, In: Journal of Neurology Neurosurgery and Psychiatry. 76, 7, p. 1028-30 3 p.

  Research output: Contribution to journal › Article › peer-review

  • Neuromyelitis Optica 100%
  • Glutens 93%
  • Transverse Myelitis 17%
  • Gliadin 17%
  • Optic Neuritis 15%
  55 Citations (Scopus)

• Hashimoto's encephalopathy: steroid resistance and response to intravenous immunoglobulins

  Jacob, S. & Rajabally, Y. A., Mar 2005, In: Journal of Neurology Neurosurgery and Psychiatry. 76, 3, p. 455-6 2 p.

  Research output: Contribution to journal › Article › peer-review
  62 Citations (Scopus)

• Hemicrania continua responsive to verapamil

  Rajabally, Y. A. & Jacob, S., Sept 2005, In: Headache. 45, 8, p. 1082-3 2 p.

  Research output: Contribution to journal › Article › peer-review

  • Verapamil 100%
  • Indomethacin 92%
  • Headache 80%
  • Headache Disorders 57%
  • Pharmaceutical Preparations 19%
  23 Citations (Scopus)

• Intracranial hypertension induced by rofecoxib

  Jacob, S. & Rajabally, Y. A., Jan 2005, In: Headache. 45, 1, p. 75-6 2 p.

  Research output: Contribution to journal › Article › peer-review

  • rofecoxib 100%
  • Intracranial Hypertension 83%
  • Pseudotumor Cerebri 47%
  • Cyclooxygenase Inhibitors 41%
  • Pharmaceutical Preparations 28%
  6 Citations (Scopus)

• Neuropathy associated with lansoprazole treatment

  Rajabally, Y. A. & Jacob, S., Jan 2005, In: Muscle & Nerve. 31, 1, p. 124-5 2 p.

  Research output: Contribution to journal › Article › peer-review
  5 Citations (Scopus)

• Optimizing the use of electrophysiology in the diagnosis of chronic inflammatory demyelinating polyneuropathy: a study of 20 cases

  Rajabally, Y. A., Jacob, S. & Hbahbih, M., Sept 2005, In: Journal of the Peripheral Nervous System. 10, 3, p. 282-92 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Chronic Inflammatory Demyelinating Polyradiculoneuropathy 100%
  • Electrophysiology 79%
  • Neural Conduction 79%
  • Neurology 50%
  • Forearm 45%
  43 Citations (Scopus)
• 2006

  Clinical heterogeneity in mild chronic inflammatory demyelinating polyneuropathy

  Rajabally, Y. A., Jacob, S. & Abbott, R. J., Sept 2006, In: European Journal of Neurology. 13, 9, p. 958-62 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Chronic Inflammatory Demyelinating Polyradiculoneuropathy 100%
  • Cerebrospinal Fluid Proteins 24%
  • Immunomodulation 20%
  • Intravenous Immunoglobulins 19%
  • Uncertainty 16%
  9 Citations (Scopus)

• Juvenile myoclonic epilepsy in an elderly patient

  Jacob, S., Martin, D. & Rajabally, Y. A., Mar 2006, In: Age and Ageing. 35, 2, p. 194-6 3 p.

  Research output: Contribution to journal › Article › peer-review

  • Juvenile Myoclonic Epilepsy 100%
  • Epileptic Syndromes 56%
  • Myoclonus 55%
  • Seizures 51%
  • Elderly 44%
  9 Citations (Scopus)

• Proximal nerve conduction studies in chronic inflammatory demyelinating polyneuropathy

  Rajabally, Y. A. & Jacob, S., Sept 2006, In: Clinical Neurophysiology. 117, 9, p. 2079-84 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Chronic Inflammatory Demyelinating Polyradiculoneuropathy 100%
  • Neural Conduction 79%
  • Upper Extremity 38%
  • Ulnar Nerve 17%
  • Axilla 17%
  27 Citations (Scopus)

• Rapidly progressive bilateral ophthalmoplegia and enlarging sellar mass caused by amelanotic melanoma

  Jacob, S., Pye, E., Hbahbih, M., Messios, N. & Rajabally, Y. A., Mar 2006, In: Journal of Neuro-Ophthalmology. 26, 1, p. 49-50 2 p.

  Research output: Contribution to journal › Article › peer-review

  • Amelanotic Melanoma 100%
  • Ophthalmoplegia 87%
  • Cavernous Sinus 83%
  • Melanoma 36%
  • Sella Turcica 31%
  17 Citations (Scopus)
• 2007

  Charcot-Marie-Tooth disease type 1A associated with acute porphyric neuropathy

  Jacob, S., Damian, M. S. & Rajabally, Y. A., Nov 2007, In: European Journal of Neurology. 14, 11, p. e10-1

  Research output: Contribution to journal › Article › peer-review
  1 Citation (Scopus)

• Short-lasting unilateral neuralgiform headache with cranial autonomic symptoms (SUNA) following vertebral artery dissection

  Jacob, S. & Rajabally, Y., Mar 2007, In: Cephalalgia. 27, 3, p. 283-5 3 p.

  Research output: Contribution to journal › Article › peer-review
  5 Citations (Scopus)
• 2008

  Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis

  Waters, P., Jarius, S., Littleton, E., Leite, M. I., Jacob, S., Gray, B., Geraldes, R., Vale, T., Jacob, A., Palace, J., Maxwell, S., Beeson, D. & Vincent, A., Jul 2008, In: Archives of Neurology. 65, 7, p. 913-9 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Transverse Myelitis 100%
  • Aquaporin 4 94%
  • Neuromyelitis Optica 93%
  • Transverse 80%
  • Antibodies 38%
  245 Citations (Scopus)

• Chronic inflammatory demyelinating polyneuropathy-like disorder associated with amyotrophic lateral sclerosis

  Rajabally, Y. A. & Jacob, S., Jul 2008, In: Muscle & Nerve. 38, 1, p. 855-60 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Chronic Inflammatory Demyelinating Polyradiculoneuropathy 100%
  • Amyotrophic Lateral Sclerosis 76%
  • Cerebrospinal Fluid Proteins 24%
  • Brachial Plexus 21%
  • Neurology 18%
  24 Citations (Scopus)

• IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis

  Leite, M. I., Jacob, S., Viegas, S., Cossins, J., Clover, L., Morgan, B. P., Beeson, D., Willcox, N. & Vincent, A., Jul 2008, In: Brain. 131, Pt 7, p. 1940-52 13 p.

  Research output: Contribution to journal › Article › peer-review

  • Myasthenia Gravis 100%
  • Cholinergic Receptors 94%
  • Immunoglobulin G 64%
  • Antibodies 47%
  • peripheral membrane protein 43K 34%
  317 Citations (Scopus)

• Myasthenia gravis seronegative for acetylcholine receptor antibodies

  Vincent, A., Leite, M. I., Farrugia, M. E., Jacob, S., Viegas, S., Shiraishi, H., Benveniste, O., Morgan, B. P., Hilton-Jones, D., Newsom-Davis, J., Beeson, D. & Willcox, N., 2008, In: Annals of the New York Academy of Sciences. 1132, p. 84-92 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Myasthenia Gravis 100%
  • Cholinergic Receptors 94%
  • Acetylcholine 91%
  • Antibodies 47%
  • Deposition 47%
  92 Citations (Scopus)

• Post-traumatic short-lasting unilateral headache with cranial autonomic symptoms (SUNA)

  Jacob, S., Saha, A. & Rajabally, Y., Sept 2008, In: Cephalalgia. 28, 9, p. 991-3 3 p.

  Research output: Contribution to journal › Article › peer-review

  • Headache 100%
  • SUNCT Syndrome 72%
  • Trigeminal Autonomic Cephalalgias 67%
  • Headache Disorders 47%
  • Injections 44%
  18 Citations (Scopus)
• 2009

  Correlating extent of neuromuscular instability with acetylcholine receptor antibodies

  Farrugia, M. E., Jacob, S., Sarrigiannis, P. G. & Kennett, R. P., Apr 2009, In: Muscle & Nerve. 39, 4, p. 489-93 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Cholinergic Receptors 100%
  • Antibodies 50%
  • Muscles 36%
  • Myasthenia Gravis 35%
  • Extremities 22%
  14 Citations (Scopus)

• Current proposed mechanisms of action of intravenous immunoglobulins in inflammatory neuropathies

  Jacob, S. & Rajabally, Y. A., Dec 2009, In: Current Neuropharmacology. 7, 4, p. 337-42 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Intravenous Immunoglobulins 100%
  • Chronic Inflammatory Demyelinating Polyradiculoneuropathy 42%
  • Immune System 23%
  • B-Lymphocytes 22%
  • Macrophages 20%
  50 Citations (Scopus)

• Immune-mediated rippling muscle disease with myasthenia gravis: a report of seven patients with long-term follow-up in two

  Schoser, B., Jacob, S., Hilton-Jones, D., Müller-Felber, W., Kubisch, C., Claus, D., Goebel, H. H., Vita, G., Vincent, A., Toscano, A. & Van den Bergh, P., Mar 2009, In: Neuromuscular Disorders. 19, 3, p. 223-8 6 p.

  Research output: Contribution to journal › Article › peer-review

  • 1 Rippling muscle disease 100%
  • Myasthenia Gravis 59%
  • Caveolin 3 27%
  • Sarcolemma 14%
  • Myalgia 12%
  24 Citations (Scopus)

• Myasthenia gravis and other neuromuscular junction disorders

  Jacob, S., Viegas, S., Lashley, D. & Hilton-Jones, D., Dec 2009, In: Practical Neurology. 9, 6, p. 364-71 8 p.

  Research output: Contribution to journal › Article › peer-review
  15 Citations (Scopus)
• 2012

  Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects

  Viegas, S., Jacobson, L., Waters, P., Cossins, J., Jacob, S., Leite, M. I., Webster, R. & Vincent, A., Apr 2012, In: Experimental Neurology. 234, 2, p. 506-12 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Passive Immunization 100%
  • Vaccination 66%
  • Phosphotransferases 64%
  • Cholinergic Receptors 57%
  • Muscles 49%
  97 Citations (Scopus)

• Presence and pathogenic relevance of antibodies to clustered acetylcholine receptor in ocular and generalized myasthenia gravis

  Jacob, S., Viegas, S., Leite, M. I., Webster, R., Cossins, J., Kennett, R., Hilton-Jones, D., Morgan, B. P. & Vincent, A., Aug 2012, In: Archives of Neurology. 69, 8, p. 994-1001 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Myasthenia Gravis 100%
  • Cholinergic Receptors 94%
  • Antibodies 47%
  • Electromyography 29%
  • Eye 29%
  84 Citations (Scopus)
• 2013

  Immunomodulation in inflammatory neuropathies: rationale and safety

  Jacob, S. & Rajabally, Y. A., Sept 2013, In: Current Drug Safety. 8, 4, p. 225-35 11 p.

  Research output: Contribution to journal › Review article › peer-review

  • Immunomodulation 100%
  • Safety 74%
  • Immunosuppressive Agent 57%
  • Drug 45%
  • Adrenal Cortex Hormone 37%
  2 Citations (Scopus)
• 2014

  Detection of branch retinal artery occlusions in Susac’s syndrome

  Boukouvala, S., Jacob, S., Lane, M., Denniston, A. K. & Burdon, M. A., 21 Jan 2014, In: BMC Research Notes. 7, 1, 56.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  File

  • Susac Syndrome 100%
  • Retinal Artery Occlusion 81%
  • Fluorescein Angiography 65%
  • Retinal 65%
  • Hearing Loss 54%
  3 Citations (Scopus)

  236 Downloads (Pure)

• Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UK

  Elsone, L., Kitley, J., Luppe, S., Lythgoe, D., Mutch, K., Jacob, S., Brown, R., Moss, K., McNeillis, B., Goh, Y. Y., Leite, M. I., Robertson, N., Palace, J. & Jacob, A., 1 Oct 2014, In: Multiple Sclerosis. 20, 11, p. 1533-1540 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Aquaporin 4 100%
  • Neuromyelitis Optica 99%
  • Azathioprine 81%
  • Observational Studies 57%
  • Retrospective Studies 49%
  76 Citations (Scopus)
• 2015

  Autoimmune encephalitis - The evolving spectrum: An Indian case series

  Jacob, S., 6 Oct 2015, In: Neurology India. 63, 5, p. 647-649 3 p.

  Research output: Contribution to journal › Editorial › peer-review

  Open Access
  3 Citations (Scopus)
• 2016

  Extreme delta brushes and BIRDs in the EEG of anti-NMDA-receptor encephalitis

  Abbas, A., Garg, A., Jain, R., Mazibrada, G. & Jacob, S., Aug 2016, In: Practical Neurology. 16, 4, p. 326-7 2 p.

  Research output: Contribution to journal › Article › peer-review
  6 Citations (Scopus)

• Tubular Aggregates and Cylindrical Spirals Have Distinct Immunohistochemical Signatures

  Brady, S., Healy, E. G., Gang, Q., Parton, M., Quinlivan, R., Jacob, S., Curtis, E., Al-Sarraj, S., Sewry, C. A., Hanna, M. G., Houlden, H., Beeson, D. & Holton, J. L., Dec 2016, In: Journal of Neuropathology & Experimental Neurology. 75, 12, p. 1171-1178 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Sarcoplasmic Reticulum 100%
  • Congenital Myasthenic Syndromes 46%
  • Congenital Structural Myopathies 46%
  • Mutation 33%
  • Muscular Diseases 31%
  4 Citations (Scopus)
• 2017

  Focal CA3 hippocampal subfield atrophy following LGI1 VGKC-complex antibody limbic encephalitis

  Miller, T. D., Chong, T. T-J., Aimola Davies, A. M., Ng, T. W. C., Johnson, M. R., Irani, S. R., Vincent, A., Husain, M., Jacob, S., Maddison, P., Kennard, C., Gowland, P. A. & Rosenthal, C. R., 1 May 2017, In: Brain. 140, 5, p. 1212-1219 8 p.

  Research output: Contribution to journal › Article › peer-review

  • Limbic Encephalitis 100%
  • Atrophy 57%
  • Antibodies 36%
  • Hippocampus 21%
  • Magnetic Resonance Imaging 17%
  49 Citations (Scopus)

• Lethal high: acute disseminated encephalomyelitis (ADEM) triggered by toxic effect of synthetic cannabinoid black mamba

  Samra, K., Boon, I. S., Packer, G. & Jacob, S., 22 Apr 2017, In: BMJ case reports. 2017

  Research output: Contribution to journal › Article › peer-review

  • Dendroaspis 100%
  • Acute Disseminated Encephalomyelitis 82%
  • Cannabinoids 65%
  • Brain Waves 42%
  • Poisons 41%
  4 Citations (Scopus)

• Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

  REGAIN Study Group, Dec 2017, In: The Lancet Neurology. 16, 12, p. 976-986 11 p.

  Research output: Contribution to journal › Article › peer-review

  • eculizumab 100%
  • Myasthenia Gravis 77%
  • Cholinergic Receptors 73%
  • Multicenter Studies 57%
  • Placebos 45%
  181 Citations (Scopus)
• 2018

  Distinct HLA associations of LGI1 and CASPR2-antibody diseases

  Binks, S., Varley, J., Lee, W., Makuch, M., Elliott, K., Gelfand, J. M., Jacob, S., Leite, M. I., Maddison, P., Chen, M., Geschwind, M. D., Grant, E., Sen, A., Waters, P., McCormack, M., Cavalleri, G. L., Barnardo, M., Knight, J. C. & Irani, S. R., 1 Aug 2018, In: Brain. 141, 8, p. 2263-2271 9 p.

  Research output: Contribution to journal › Article › peer-review

  • Contactins 100%
  • HLA Antigens 63%
  • Leucine 62%
  • Glioma 56%
  • Antibodies 34%
  48 Citations (Scopus)

• Serological and experimental studies in different forms of myasthenia gravis

  Vincent, A., Huda, S., Cao, M., Cetin, H., Koneczny, I., Rodriguez Cruz, P. M., Jacobson, L., Viegas, S., Jacob, S., Woodhall, M., Nagaishi, A., Maniaol, A., Damato, V., Leite, M. I., Cossins, J., Webster, R., Palace, J. & Beeson, D., Feb 2018, In: Annals of the New York Academy of Sciences. 1413, 1, p. 143-153 11 p.

  Research output: Contribution to journal › Review article › peer-review

  • Myasthenia Gravis 100%
  • Acetylcholine 91%
  • Experimental Study 81%
  • Ryanodine 63%
  • Low-Density Lipoprotein 50%
  22 Citations (Scopus)

• Seronegative antibody-mediated neurology after immune checkpoint inhibitors

  Wilson, R., Menassa, D. A., Davies, A. J., Michael, S., Hester, J., Kuker, W., Collins, G. P., Cossins, J., Beeson, D., Steven, N., Maddison, P., Rinaldi, S., Jacob, S. & Irani, S. R., May 2018, In: Annals of Clinical and Translational Neurology. 5, 5, p. 640-645 6 p.

  Research output: Contribution to journal › Article › peer-review

  • Neurology 100%
  • Antibodies 52%
  • Transverse Myelitis 45%
  • Myelitis 43%
  • Myasthenia Gravis 36%
  20 Citations (Scopus)
• 2019

  Eculizumab improves fatigue in refractory generalized myasthenia gravis

  REGAIN Study Group & Jacob, S., Aug 2019, In: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 28, 8, p. 2247-2254 8 p.

  Research output: Contribution to journal › Article › peer-review

  • eculizumab 100%
  • Myasthenia Gravis 77%
  • fatigue 72%
  • Fatigue 55%
  • Activities of Daily Living 21%
  15 Citations (Scopus)

• Enlarged and Enhancing Optic Nerves in Advanced Glial Fibrillary Acidic Protein Meningoencephalomyelitis

  White, D., Mollan, S. P., Ramalingam, S., Nagaraju, S., Hayton, T. & Jacob, S., Sept 2019, In: Journal of Neuro-Ophthalmology. 39, 3, p. 411-415 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Glial Fibrillary Acidic Protein 100%
  • Optic Nerve 92%
  • Cerebrospinal Fluid 52%
  • Intracranial Hypertension 35%
  • Spinal Puncture 35%
  3 Citations (Scopus)

• False-positive acetylcholine receptor antibody results in patients without myasthenia gravis

  Maddison, P., Sadalage, G., Ambrose, P. A., Jacob, S. & Vincent, A., 15 Jul 2019, In: Journal of Neuroimmunology. 332, p. 69-72 4 p.

  Research output: Contribution to journal › Article › peer-review

  • Myasthenia Gravis 100%
  • Cholinergic Receptors 94%
  • Radioimmunoprecipitation Assay 54%
  • Antibodies 47%
  • Epitopes 14%

• Glutamate Receptor Antibodies in Autoimmune Central Nervous System Disease: Basic Mechanisms, Clinical Features, and Antibody Detection

  Scotton, W. J., Karim, A. & Jacob, S., 2019, In: Methods in molecular biology. 1941, p. 225-255 31 p.

  Research output: Contribution to journal › Article › peer-review

  • Autoimmune Diseases of the Nervous System 100%
  • Glutamate Receptors 72%
  • Central Nervous System Diseases 72%
  • Encephalitis 43%
  • Antibodies 36%

• Healthcare resource utilization by patients with treatment-refractory myasthenia gravis in England

  Harris, L., Graham, S., MacLachlan, S., Exuzides, A. & Jacob, S., Jul 2019, In: Journal of Medical Economics. 22, 7, p. 691-697 7 p.

  Research output: Contribution to journal › Article › peer-review

  • Myasthenia Gravis 100%
  • England 85%
  • utilization 68%
  • Healthcare 66%
  • Delivery of Health Care 52%
  1 Citation (Scopus)

• Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study

  REGAIN Study Group & Jacob, S., 15 Dec 2019, In: Journal of the Neurological Sciences. 407, p. 116419

  Research output: Contribution to journal › Article › peer-review

  • eculizumab 100%
  • Myasthenia Gravis 77%
  • Safety 38%
  • Complement Inactivating Agents 16%
  • Placebos 15%
  3 Citations (Scopus)

• Long-term safety and efficacy of eculizumab in generalized myasthenia gravis

  REGAIN Study Group, Jul 2019, In: Muscle & Nerve. 60, 1, p. 14-24 11 p.

  Research output: Contribution to journal › Article › peer-review

  • eculizumab 100%
  • Myasthenia Gravis 77%
  • Safety 38%
  • Meningococcal Infections 12%
  • Muscle Strength 9%
  56 Citations (Scopus)

• Primary angiitis of the central nervous system (PACNS) - a rare and serious, but treatable entity

  Jacob, S., 28 Jul 2019, In: Neurology India. 67, 3, p. 942-944 3 p.

  Research output: Contribution to journal › Article › peer-review

• Restless leg syndrome in patients with liver cirrhosis: Waiting for the shoe to drop

  Bose, S. & Jacob, S., 28 Jul 2019, In: Neurology India. 67, 3, p. 657-659 3 p.

  Research output: Contribution to journal › Article › peer-review
  1 Citation (Scopus)

• Slowly progressive distal muscle weakness: neuropathy or myopathy?

  Nahari, Y., Abbas, A., Curtis, E. & Jacob, S., 3 Apr 2019, In: BMJ case reports. 12, 4

  Research output: Contribution to journal › Article › peer-review

  • Nonaka type Distal myopathy 100%
  • Muscular Diseases 62%
  • Muscle Weakness 61%
  • Distal Myopathies 47%
  • Neurophysiology 36%
• 2020

  Consistent improvement with eculizumab across muscle groups in myasthenia gravis

  REGAIN Study Group & Jacob, S., Aug 2020, In: Annals of Clinical and Translational Neurology. 7, 8, p. 1327-1339 13 p.

  Research output: Contribution to journal › Article › peer-review

  • eculizumab 100%
  • Myasthenia Gravis 77%
  • Muscles 39%
  • Cholinergic Receptors 24%
  • Activities of Daily Living 21%
  1 Citation (Scopus)

• COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)

  CARE-MG Study Group, Dec 2020, In: The Lancet Neurology. 19, 12, p. 970-971 2 p.

  Research output: Contribution to journal › Article › peer-review
  8 Citations (Scopus)

• Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic

  International MG/COVID-19 Working Group, 15 May 2020, In: Journal of the Neurological Sciences. 412, p. 116803

  Research output: Contribution to journal › Article › peer-review
  55 Citations (Scopus)

• Human hippocampal CA3 damage disrupts both recent and remote episodic memories

  Miller, T. D., Chong, T. T-J., Aimola Davies, A. M., Johnson, M. R., Irani, S. R., Husain, M., Ng, T. W., Jacob, S., Maddison, P., Kennard, C., Gowland, P. A. & Rosenthal, C. R., 24 Jan 2020, In: eLife. 9

  Research output: Contribution to journal › Article › peer-review

  • Long-Term Memory 100%
  • Episodic Memory 98%
  • Hippocampus 69%
  • Temporal Lobe 26%
  • Magnetic Resonance Imaging 9%
  10 Citations (Scopus)

• 'Minimal symptom expression' in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab

  REGAIN Study Group, Jul 2020, In: Journal of Neurology. 267, 7, p. 1991-2001 11 p.

  Research output: Contribution to journal › Article › peer-review

  • eculizumab 100%
  • Myasthenia Gravis 77%
  • Cholinergic Receptors 73%
  • Antibodies 36%
  • Activities of Daily Living 32%
  3 Citations (Scopus)